Tonix Pharmaceuticals Holding Corp Share Price Nasdaq
Equities
US8902604094
Pharmaceuticals
Sales 2024 * | 16.33M 1.31B | Sales 2025 * | 18.2M 1.46B | Capitalization | 18.54M 1.48B |
---|---|---|---|---|---|
Net income 2024 * | -96M -7.68B | Net income 2025 * | -88M -7.04B | EV / Sales 2024 * | 1.13 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.02 x |
P/E ratio 2024 * |
-0.19
x | P/E ratio 2025 * |
-0.28
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.99% |
1st Jan change | Capi. | |
---|---|---|
-2.47% | 88.14B | |
+3.29% | 40.44B | |
-15.40% | 32.24B | |
+51.96% | 24.39B | |
-14.35% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
-13.41% | 12.14B | |
+5.17% | 8.87B |